US Map / Virginia
State VA

Clinical Trials in Virginia

Recruiting clinical trials with at least one study location in Virginia. Data updated daily from ClinicalTrials.gov.

Total Trials
287
Recruiting Now
287
← Back to US Map
Top Conditions in Virginia
Breast Cancer (8)Advanced Solid Tumor (7)Prostate Cancer (6)Advanced Solid Tumors (6)Non Small Cell Lung Cancer (5)NSCLC (5)Colorectal Cancer (5)Endometrial Cancer (4)Ovarian Cancer (4)Diabetic Macular Edema (4)Non-Small Cell Lung Cancer (4)Cervical Cancer (3)

Frequently Asked Questions — Clinical Trials in Virginia

How many clinical trials are currently recruiting in Virginia?
ClinicalMetric currently tracks 287 actively recruiting clinical trials with at least one location in Virginia. The total number of registered studies—including active but not currently enrolling trials—is 287. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Virginia?
Virginia hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Advanced Solid Tumor, Prostate Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Virginia serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Virginia?
To join a clinical trial in Virginia, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Virginia maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Virginia

NCT03945162 Phase 2
Recruiting
Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Mus...
Condition
Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG
Enrollment
90 pts
Location
United States, Canada
Sponsor
Theralase® Technologies Inc.
View Trial →
NCT06667141 Phase 1
Recruiting
Phase 1 Study of ACR-2316 in Specific Advanced Solid Tumors
Condition
Specific Advanced Solid Tumors
Enrollment
100 pts
Location
United States
Sponsor
Acrivon Therapeutics
View Trial →
NCT04796220 Phase 1
Recruiting
Focused Ultrasound and Gemcitabine in Breast Cancer
Condition
Breast Cancer
Enrollment
32 pts
Location
United States
Sponsor
Patrick Dillon, MD
View Trial →
NCT04647240 Phase 2
Recruiting
MTX-001 for the Treatment of Non-Healing Venous Stasis Ulcers
Condition
Venous Stasis Ulcer
Enrollment
80 pts
Location
United States
Sponsor
Merakris Therapeutics
View Trial →
NCT06926920 Phase 1, Phase 2
Recruiting
A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Pa...
Condition
Triple Negative Breast Cancer
Enrollment
100 pts
Location
United States, Australia, South Korea
Sponsor
Gilead Sciences
View Trial →
NCT05775523 N/A
Recruiting
A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatro...
Condition
Growth Hormone Deficiency
Enrollment
500 pts
Location
United States
Sponsor
Ascendis Pharma Endocrinology
View Trial →
NCT06380517 Phase 3
Recruiting
Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
Condition
Amblyopia
Enrollment
238 pts
Location
United States
Sponsor
Jaeb Center for Health Researc
View Trial →
NCT05722418 Phase 1
Recruiting
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/...
Condition
Relapsed/Refractory Multiple Myeloma
Enrollment
50 pts
Location
United States
Sponsor
Caribou Biosciences, Inc.
View Trial →
NCT06873581 Phase 3
Recruiting
Pivotal Study of Voro Urologic Scaffold
Condition
Radical Prostatectomy
Enrollment
266 pts
Location
United States
Sponsor
Levee Medical, Inc.
View Trial →
NCT04031677 Phase 3
Recruiting
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sa...
Condition
Retroperitoneal Sarcoma
Enrollment
250 pts
Location
United States, Australia, Canada
Sponsor
European Organisation for Rese
View Trial →
NCT07030257 Phase 1, Phase 2
Recruiting
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Condition
Solid Tumor Malignancies
Enrollment
150 pts
Location
United States
Sponsor
Tasca Therapeutics
View Trial →
NCT07287995 Phase 1, Phase 2
Recruiting
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People W...
Condition
Locally Advanced or Metastatic Malignant Solid Tumors
Enrollment
428 pts
Location
United States, Japan
Sponsor
Astellas Pharma Global Develop
View Trial →
NCT04798261 N/A
Recruiting
Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With t...
Condition
Pulmonary Embolism
Enrollment
1,500 pts
Location
United States, Australia, Brazil
Sponsor
Penumbra Inc.
View Trial →
NCT06545331 Phase 1
Recruiting
Study of XB010 in Subjects With Solid Tumors
Condition
Locally Advanced or Metastatic Solid Tumors
Enrollment
396 pts
Location
United States, United Kingdom
Sponsor
Exelixis
View Trial →
NCT07187531 Phase 2
Recruiting
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Pro...
Condition
Type 1 Diabetes
Enrollment
159 pts
Location
United States, Australia, Austria
Sponsor
SAb Biotherapeutics, Inc.
View Trial →
NCT05880537 N/A
Recruiting
Decellularized Femoral Artery Allograft (Nexeon AVX) Prospective Registry
Condition
End-Stage Renal Disease
Enrollment
100 pts
Location
United States
Sponsor
LifeNet Health
View Trial →
NCT07087054 Phase 3
Recruiting
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
Condition
Carcinoid Syndrome
Enrollment
141 pts
Location
United States, Argentina, Brazil
Sponsor
Crinetics Pharmaceuticals Inc.
View Trial →
NCT06614894 Phase 2, Phase 3
Recruiting
An Open Label Dose Escalation Study to Assess the Safety, Tolerability, and Phar...
Condition
Sanfilippo Syndrome
Enrollment
10 pts
Location
United States
Sponsor
Ozlem Goker-Alpan
View Trial →
NCT03193151 N/A
Recruiting
Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation
Condition
Liver Dysfunction
Enrollment
300 pts
Location
United States, Australia, Canada
Sponsor
University of Alberta
View Trial →
NCT06619561 Phase 2
Recruiting
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host ...
Condition
Chronic Graft-Versus-Host Disease (cGVHD)
Enrollment
48 pts
Location
United States
Sponsor
Deciphera Pharmaceuticals, LLC
View Trial →
NCT06850805 Phase 3
Recruiting
Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adole...
Condition
Chronic Rhinosinusitis Without Nasal Polyps
Enrollment
84 pts
Location
United States
Sponsor
Optinose US Inc.
View Trial →
NCT06021769 N/A
Recruiting
Pessary Experience Study
Condition
Pelvic Organ Prolapse
Enrollment
30 pts
Location
United States
Sponsor
University of Virginia
View Trial →
NCT04614103 Phase 2
Recruiting
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Condition
Metastatic Non Small Cell Lung Cancer
Enrollment
170 pts
Location
United States, Australia, Canada
Sponsor
Iovance Biotherapeutics, Inc.
View Trial →
NCT06559150 Phase 2
Recruiting
A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis
Condition
Non-cystic Fibrosis Bronchiectasis
Enrollment
284 pts
Location
United States, Italy, Spain
Sponsor
Verona Pharma, Inc., a subsidi
View Trial →
NCT07213674 Phase 3
Recruiting
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Particip...
Condition
Metastatic Castration-resistant Prostate Cancer
Enrollment
750 pts
Location
United States, Australia, Austria
Sponsor
Amgen
View Trial →
Page 3 of 12 — 287 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology